Corticotropin Patent Expiration
Corticotropin is used for promoting new vessel formation in ophthalmic diseases. It was first introduced by Sanofi Aventis Us Llc
Corticotropin Patents
Given below is the list of patents protecting Corticotropin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Purified Cortrophin Gel | US11975047 | Methods for storing and warming purified corticotropin compositions | Oct 27, 2043 | Ani Pharms |
| Purified Cortrophin Gel | US12102662 | Methods for storing and warming purified corticotropin compositions | Oct 27, 2043 | Ani Pharms |
| Acthar Gel | US11752199 | Methods of modulating pericytes | Feb 25, 2041 | Mallinckrodt Ireland |
| Acthar Gel (autoinjector) | US11752199 | Methods of modulating pericytes | Feb 25, 2041 | Mallinckrodt Ireland |
Corticotropin's Family Patents
Explore Our Curated Drug Screens
Corticotropin Generic API Manufacturers
Only one generic application has been filed for Corticotropin.
Given below is the list of companies who have filed for Corticotropin generic, along with the locations of their manufacturing plants worldwide.
1. WATSON LABS
Watson Laboratories Inc has filed for 1 generic for Corticotropin. Given below are the details of the strengths of this generic introduced by Watson Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 40 UNITS/VIAL | injectable | Discontinued | INJECTION | N/A | Nov 21, 1984 |